Physician profile
Daniel Tran
NPI 1477081396
$13,700.29
in general payments reported to CMS, 2019-2025
35 companies · $1,452 in 2025
The $1,452 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $144 · 2021: $1,214 · 2022: $4,232 · 2023: $4,293 · 2024: $2,243 · 2025: $1,452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,439 · Grant: $2,000 · Travel and Lodging: $322 · Education: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,439.33 |
| Grant | $2,000.00 |
| Travel and Lodging | $322.46 |
| Education | $225.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,638.82 | 2021-2025 | Ensite, Assurity, Perclose Prostyle |
| Boston Scientific Corporation | $1,722.92 | 2021-2025 | Avvigo Guidance System, Watchman Access System |
| Atricure, INC. | $1,175.67 | 2022-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $870.51 | 2021-2025 | Lifevest |
| Medtronic, INC. | $666.79 | 2021-2024 | Symplicity G3, Azure Xt Dr Mri Surescan |
| Amgen INC. | $510.63 | 2021-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $439.46 | 2022-2024 | Camzyos |
| Janssen Pharmaceuticals, INC | $362.45 | 2019-2024 | Xarelto |
| Shockwave Medical, INC | $344.37 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Impulse Dynamics (USA) INC. | $341.21 | 2023 | Optimizer |
| W. L. Gore & Associates, INC. | $284.32 | 2022-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore-Tex Vascular Graft |
| Novartis Pharmaceuticals Corporation | $275.63 | 2021-2025 | |
| Astrazeneca Pharmaceuticals Lp | $262.51 | 2021-2025 | Wainua, Farxiga |
| Abiomed | $221.87 | 2024-2025 | Impella |
| Pfizer INC. | $215.34 | 2020-2024 |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.